• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A quantitative structure-activity relationship study on a novel class of calcium-entry blockers: 1-[(4-(aminoalkoxy)phenyl)sulphonyl]indolizines.

作者信息

Gupta S P, Mathur Anoop N, Nagappa A N, Kumar Dalip, Kumaran S

机构信息

Department of Chemistry, Birla Institute of Technology and Science, Pilani 333031, India.

出版信息

Eur J Med Chem. 2003 Oct;38(10):867-73. doi: 10.1016/j.ejmech.2003.08.001.

DOI:10.1016/j.ejmech.2003.08.001
PMID:14575933
Abstract

A quantitative structure-activity relationship (QSAR) study has been made on two different series of 1-[(4-(aminoalkoxy)phenyl)sulphonyl]indolizines acting as calcium entry blockers, using some physicochemical and structural parameters. Two different assays were reported for both the series: (IC(50))(A), referring to the molar concentration of the compound required to reduce [3H] nitrendipine binding by 50%, and (IC(50))(B), referring to that required to block Ca(2+) induced concentration of K(+) depolarised rat aorta by 50%. For series 1, where the 2-position substituents of indolizine ring were varied along with the aminoalkoxy moieties of the phenyl ring, the QSAR analysis shows that the 2-position substituents can equally affect both the activities through their hydrophobic and electronic properties and the aminoalkoxy moiety through some steric effects. For series 2, where the indolizine ring has been replaced by varying heterocyclic rings, along with the changes in aminoalkoxy moiety of the phenyl ring, the QSAR exhibits that these different heterocyclic rings affect both the activities through some steric roles, altering the conformations of the receptors from system A to system B. Among the different heterocyclic rings, the N-substituted indole ring is shown to be more conducive to both the activities than any other ring. However, a 5-membered ring is indicated to be less effective than a 9- or 10-membered ring for activity B. Additionally, the amino moieties having phenyl ring with methoxy groups at 3,4,and 5-positions are shown to favour both A and B activities.

摘要

相似文献

1
A quantitative structure-activity relationship study on a novel class of calcium-entry blockers: 1-[(4-(aminoalkoxy)phenyl)sulphonyl]indolizines.
Eur J Med Chem. 2003 Oct;38(10):867-73. doi: 10.1016/j.ejmech.2003.08.001.
2
Novel heterocyclic analogues of the new potent class of calcium entry blockers: 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.
J Med Chem. 1993 May 14;36(10):1425-33. doi: 10.1021/jm00062a015.
3
A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.一类新型的钙通道阻滞剂:1[[4-(氨基烷氧基)苯基]磺酰基]中氮茚。
J Med Chem. 1992 Mar 20;35(6):981-8. doi: 10.1021/jm00084a002.
4
Quantitative structure-activity relationship studies on some series of calcium channel blockers.一些系列钙通道阻滞剂的定量构效关系研究
Mol Divers. 2004;8(4):357-63. doi: 10.1023/b:modi.0000047521.70687.52.
5
The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.新一代带有4-苯氧基丙醇胺的二氢吡啶类钙阻滞剂具有α/β肾上腺素能受体拮抗作用和长效降压活性。
Bioorg Med Chem. 2002 Mar;10(3):719-30. doi: 10.1016/s0968-0896(01)00318-2.
6
Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers.1,4 - 二氢吡啶类钙通道阻滞剂的合成、对接模拟、生物学评价及三维定量构效关系研究
Chem Pharm Bull (Tokyo). 2017;65(10):893-903. doi: 10.1248/cpb.c17-00186.
7
Understanding the Action of Indolizines as Biologically Active Moieties: A Molecular Dynamics Study.理解中氮茚作为生物活性部分的作用:一项分子动力学研究。
Curr Comput Aided Drug Des. 2017;13(1):22-29. doi: 10.2174/1573409912666161004160827.
8
SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.SR 33557,一种新型钙拮抗剂:与脑膜中[3H] -(±)-尼群地平及[3H] -(-)-去甲氧基维拉帕米结合位点的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):31-6. doi: 10.1007/BF00165122.
9
Anticancer activity of novel pyrido[2,3-b]indolizine derivatives: the relevance of phenolic substituents.新型吡啶并[2,3-b]吲哚嗪衍生物的抗癌活性:酚取代基的相关性。
Anticancer Res. 2014 Apr;34(4):1673-7.
10
Active conformation of 1,4-dihydropyridine calcium entry blockers. Effect of size of 2-aryl substituent on rotameric equilibria and receptor binding.1,4 - 二氢吡啶类钙通道阻滞剂的活性构象。2 - 芳基取代基大小对旋转异构体平衡及受体结合的影响。
J Med Chem. 1991 Aug;34(8):2521-4. doi: 10.1021/jm00112a030.

引用本文的文献

1
Computer aided drug design based on 3D-QSAR and molecular docking studies of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amine derivatives as PIM2 inhibitors: a proposal to chemists.基于5-(1H-吲哚-5-基)-1,3,4-噻二唑-2-胺衍生物作为PIM2抑制剂的3D-QSAR和分子对接研究的计算机辅助药物设计:给化学家的建议
In Silico Pharmacol. 2018 Mar 28;6(1):5. doi: 10.1007/s40203-018-0043-7. eCollection 2018.
2
QSAR study and rustic ligand-based virtual screening in a search for aminooxadiazole derivatives as PIM1 inhibitors.作为PIM1抑制剂的氨基恶二唑衍生物的定量构效关系研究及基于质朴配体的虚拟筛选
Chem Cent J. 2018 Mar 22;12(1):32. doi: 10.1186/s13065-018-0401-x.
3
QSAR studies on PIM1 and PIM2 inhibitors using statistical methods: a rustic strategy to screen for 5-(1H-indol-5-yl)-1,3,4-thiadiazol analogues and predict their PIM inhibitory activity.
使用统计方法对PIM1和PIM2抑制剂进行定量构效关系研究:一种筛选5-(1H-吲哚-5-基)-1,3,4-噻二唑类似物并预测其PIM抑制活性的质朴策略。
Chem Cent J. 2017 May 19;11(1):41. doi: 10.1186/s13065-017-0269-1.
4
Iodine-mediated C-H functionalization of methyl ketones: a one-pot synthesis of functionalized indolizines via the 1,3-dipolar cycloaddition reaction between pyridinium ylides and ynones.碘介导的甲基酮C-H官能化:通过吡啶叶立德与炔酮之间的1,3-偶极环加成反应一锅法合成官能化中氮茚。
Mol Divers. 2017 Feb;21(1):1-8. doi: 10.1007/s11030-016-9720-9. Epub 2017 Jan 11.
5
(11aS)-1,5,11,11a-Tetra-hydro-1-benzo-thieno[3,2-f]indolizin-3(2H)-one.(11aS)-1,5,11,11a-四氢-1-苯并噻吩并[3,2-f]中氮茚-3(2H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2013 Nov 23;69(Pt 12):o1819-20. doi: 10.1107/S1600536813031693.
6
Novel one-pot green synthesis of indolizines biocatalysed by Candida antarctica Lipases.新型一锅法绿色合成吲哚嗪生物催化南极假丝酵母脂肪酶。
Mar Drugs. 2013 Feb 6;11(2):431-9. doi: 10.3390/md11020431.
7
(8aR,9R)-9-Hy-droxy-7,8,8a,9-tetra-hydro-furo[3,2-f]indolizin-6(4H)-one.(8aR,9R)-9-羟基-7,8,8a,9-四氢呋喃并[3,2-f]中氮茚-6(4H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2012 Oct 1;68(Pt 10):o3034-5. doi: 10.1107/S1600536812040378. Epub 2012 Sep 29.
8
(6S,7S,8S,8aS)-6-Ethyl-3-oxo-1,2,3,5,6,7,8,8a-octa-hydro-indolizine-7,8-diyl diacetate.(6S,7S,8S,8aS)-6-乙基-3-氧代-1,2,3,5,6,7,8,8a-八氢中氮茚-7,8-二基二乙酸酯
Acta Crystallogr Sect E Struct Rep Online. 2012 Mar 1;68(Pt 3):o662-3. doi: 10.1107/S1600536812005144. Epub 2012 Feb 10.
9
(4R,6S,7S,8S,8aS)-6-Ethyl-7,8-dihy-droxy-4-methyl-1,2,3,5,6,7,8,8a-octa-hydro-indolizin-4-ium iodide.(4R,6S,7S,8S,8aS)-6-乙基-7,8-二羟基-4-甲基-1,2,3,5,6,7,8,8a-八氢中氮茚-4-碘化物
Acta Crystallogr Sect E Struct Rep Online. 2011 Dec 1;67(Pt 12):o3520-1. doi: 10.1107/S1600536811051099. Epub 2011 Nov 30.
10
(8aRS)-8,8a-Dihydro-furo[3,2-f]indolizine-6,9(4H,7H)-dione.(8aRS)-8,8a-二氢-呋喃并[3,2-f]中氮茚-6,9(4H,7H)-二酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Aug 1;67(Pt 8):o2035. doi: 10.1107/S1600536811027383. Epub 2011 Jul 13.